Lynn L. Bergeson Presents “New TSCA’s Impact On Biotechnology” With The National Academies Of Scienc

On August 2, 2016, Lynn L. Bergeson, Managing Partner of B&C, presented the webinar "New TSCA's Impact on Biotechnology," with the National Academies of Sciences, Engineering, and Medicine (NAS). This webinar, available for free on the NAS website, includes an overview of TSCA updates resulting from the passage of the Frank R. Lautenberg Chemical Safety for the 21st Century Act. Ms. Bergeson focused specifically on how these updates could impact the regulation of biotechnology, especially under Sections 3, 4, 5, and 26. Changes include: how EPA defines "conditions of use" and "potentially exposed or susceptible subpopulations," and applies them to intergeneric microorganisms; an expansion of EPA's authority to compel testing; and a requirement for EPA to provide an affirmative determination when reviewing Section 5 notifications.